ARE
Alexandria Real Estate Equities
Earnings and EPS analysis
- Stocks
- Real Estate
- NYSE: ARE
- Earnings
EPS in 2026 (TTM): -$6.27
Last Report Period Date: Mar 31, 2026
As of June 2026, ARE's current EPS stands at -$6.27, according to the latest financial reports. For the year 2025, the company recorded an earnings per share (EPS) of -$8.44, which marks a drop compared to its EPS of $1.8 in 2024. ARE reported an EPS of $2.1 for the quarterly report ending on Mar 31, 2026.
ARE earnings history
For 2025, Alexandria Real Estate Equities's EPS was -$8.44, a drop of 568.9% from $1.8 in 2024. For the fiscal quarter that ended on Mar 31, 2026, the per-share earnings was $2.1, showing a 3,100% increase from the same quarter last year. For the twelve months ending March 2026, the EPS is -$6.27. For the year 2024, the yearly earnings per share was $1.8, marking an increase of 233.3% from 2023.
ARE earnings chart
ARE EPS growth history
Alexandria Real Estate Equities has registered an increase in EPS of 3,100% during the last 12 months (YoY, quarterly).
ARE Earnings Waterfall
ARE Earnings vs Peers
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| BMY Bristol Myers Squibb Co | 15.55 | 178.7% | 5.3% | N/A |
| GILD Gilead Sciences Inc | 16.85 | 1,700% | 23.2% | 132.8% |
| PFE Pfizer Inc | 18.87 | -3.5% | -37.4% | -3.7% |
| AMGN Amgen Inc | 23.96 | 88.1% | 5.6% | 2.9% |
| ILMN Illumina Inc | 29.88 | 171.1% | N/A | 4.1% |
| LLY ELI LILLY & Co | 39.27 | 95.6% | 49.2% | 27.5% |
| ALNY Alnylam Pharmaceuticals Inc | 66.1 | 209.6% | N/A | N/A |
| ARE Alexandria Real Estate Equities Inc | N/A | -568.9% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.